$5.16 Billion is the total value of Bellevue Group AG's 239 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 24.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IONS | Sell | IONIS PHARMACEUTICALS INC | $396,189,000 | -22.2% | 8,379,642 | -0.6% | 7.68% | -4.9% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $302,932,000 | -0.4% | 1,273,089 | -8.4% | 5.88% | +21.8% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $282,107,000 | -20.9% | 3,259,474 | -1.8% | 5.47% | -3.3% |
| INCY | Sell | INCYTE CORP | $243,416,000 | -20.7% | 3,324,000 | -5.5% | 4.72% | -3.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $193,237,000 | -10.0% | 1,775,264 | -4.8% | 3.75% | +10.0% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $138,565,000 | -26.1% | 3,905,444 | -0.5% | 2.69% | -9.6% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $137,874,000 | -3.2% | 7,663,956 | -4.6% | 2.67% | +18.4% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $119,540,000 | -20.4% | 1,331,328 | -4.1% | 2.32% | -2.7% |
| MRNA | Sell | MODERNA INC | $118,308,000 | +22.6% | 3,950,181 | -20.0% | 2.29% | +49.9% |
| ABT | Sell | ABBOTT LABS | $101,342,000 | -12.0% | 1,284,272 | -3.1% | 1.96% | +7.7% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $67,193,000 | -49.9% | 1,205,472 | -42.3% | 1.30% | -38.7% |
| HUM | Sell | HUMANA INC | $62,213,000 | -25.4% | 198,118 | -12.9% | 1.21% | -8.8% |
| BDX | Sell | BECTON DICKINSON & CO | $56,768,000 | -17.2% | 247,064 | -2.0% | 1.10% | +1.3% |
| ILMN | Sell | ILLUMINA INC | $54,348,000 | -26.1% | 198,988 | -10.2% | 1.05% | -9.6% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $50,290,000 | -29.6% | 1,541,225 | -2.4% | 0.98% | -13.9% |
| DHR | Sell | DANAHER CORPORATION | $47,818,000 | -15.0% | 345,481 | -5.8% | 0.93% | +3.9% |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $44,638,000 | -49.6% | 708,976 | -0.9% | 0.87% | -38.4% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $37,037,000 | -34.9% | 371,337 | -2.6% | 0.72% | -20.4% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $35,325,000 | -54.6% | 203,076 | -27.1% | 0.68% | -44.4% |
| TDOC | Sell | TELADOC HEALTH INC | $31,193,000 | -50.3% | 201,235 | -73.2% | 0.60% | -39.3% |
| MOH | Sell | MOLINA HEALTHCARE INC | $17,912,000 | +1.1% | 128,206 | -1.8% | 0.35% | +23.5% |
| OMCL | Sell | OMNICELL INC | $12,863,000 | -19.8% | 196,136 | -0.1% | 0.25% | -2.0% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $12,551,000 | +5.2% | 195,038 | -2.6% | 0.24% | +28.6% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $11,217,000 | -46.7% | 39,552 | -39.0% | 0.22% | -34.7% |
| QDEL | Sell | QUIDEL CORP | $11,146,000 | -56.0% | 113,955 | -66.2% | 0.22% | -46.3% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $10,841,000 | +16.6% | 133,259 | -2.4% | 0.21% | +42.9% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $10,596,000 | -67.1% | 104,832 | -51.2% | 0.20% | -59.8% |
| IDXX | Sell | IDEXX LABS INC | $10,153,000 | -18.1% | 41,911 | -11.7% | 0.20% | +0.5% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $9,937,000 | -15.4% | 2,411,926 | -1.2% | 0.19% | +3.8% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $9,945,000 | -27.2% | 552,800 | -4.0% | 0.19% | -10.6% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $9,326,000 | +12.9% | 19,100 | -13.2% | 0.18% | +38.2% |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $8,819,000 | -41.3% | 197,420 | -23.4% | 0.17% | -28.2% |
| INSP | Sell | INSPIRE MED SYS INC | $8,272,000 | -57.7% | 137,225 | -47.9% | 0.16% | -48.4% |
| NVRO | Sell | NEVRO CORP | $7,989,000 | -38.0% | 79,906 | -27.2% | 0.16% | -24.0% |
| GH | Sell | GUARDANT HEALTH INC | $7,328,000 | -14.9% | 105,294 | -4.4% | 0.14% | +4.4% |
| COO | Sell | COOPER COS INC | $6,987,000 | -47.6% | 25,345 | -39.0% | 0.14% | -36.3% |
| XENT | Sell | INTERSECT ENT INC | $6,459,000 | -54.6% | 545,022 | -4.5% | 0.12% | -44.4% |
| INGN | Sell | INOGEN INC | $6,375,000 | -32.3% | 123,395 | -10.4% | 0.12% | -16.8% |
| TXG | Sell | 10X GENOMICS INC | $5,849,000 | -40.6% | 93,847 | -27.3% | 0.11% | -27.6% |
| XRAY | Sell | DENTSPLY SIRONA INC | $4,972,000 | -47.1% | 128,038 | -22.9% | 0.10% | -35.6% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $4,917,000 | -57.0% | 166,000 | -47.4% | 0.10% | -47.5% |
| QGEN | Sell | QIAGEN NV | $3,852,000 | -29.2% | 92,600 | -42.4% | 0.08% | -12.8% |
| ABBV | Sell | ABBVIE INC | $1,935,000 | -48.6% | 25,400 | -40.2% | 0.04% | -36.7% |
| XLRN | Sell | ACCELERON PHARMA INC | $1,950,000 | +52.0% | 21,700 | -10.3% | 0.04% | +90.0% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $1,833,000 | -42.8% | 67,400 | -58.5% | 0.04% | -29.4% |
| FGEN | Sell | FIBROGEN INC | $1,307,000 | -20.8% | 37,600 | -2.3% | 0.02% | -3.8% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $1,222,000 | -41.8% | 15,900 | -2.5% | 0.02% | -27.3% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $787,000 | -70.6% | 48,500 | -67.3% | 0.02% | -64.3% |
| KURA | Sell | KURA ONCOLOGY INC | $568,000 | -73.8% | 57,100 | -63.8% | 0.01% | -67.6% |
| MCK | Sell | MCKESSON CORP | $526,000 | -35.2% | 3,892 | -33.7% | 0.01% | -23.1% |
| A | Sell | AGILENT TECHNOLOGIES INC | $444,000 | -71.1% | 6,200 | -65.6% | 0.01% | -62.5% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $453,000 | -40.4% | 71,200 | -2.3% | 0.01% | -25.0% |
| HSIC | Exit | HENRY SCHEIN INC | $0 | – | -5,948 | -100.0% | -0.01% | – |
| CERN | Exit | CERNER CORP | $0 | – | -6,200 | -100.0% | -0.01% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -12,300 | -100.0% | -0.01% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -62,200 | -100.0% | -0.01% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -26,100 | -100.0% | -0.02% | – |
| AMRX | Exit | AMNEAL PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.02% | – |
| BIB | Exit | PROSHARES TR | $0 | – | -25,000 | -100.0% | -0.02% | – |
| MYL | Exit | MYLAN N V | $0 | – | -80,000 | -100.0% | -0.02% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -20,200 | -100.0% | -0.03% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -15,500 | -100.0% | -0.03% | – |
| BNFT | Exit | BENEFITFOCUS INC | $0 | – | -90,463 | -100.0% | -0.03% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -30,000 | -100.0% | -0.04% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -168,400 | -100.0% | -0.05% | – |
| FIT | Exit | FITBIT INCcl a | $0 | – | -570,959 | -100.0% | -0.06% | – |
| SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -530,230 | -100.0% | -0.07% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -126,639 | -100.0% | -0.15% | – |
| WMGI | Exit | WRIGHT MED GROUP NV | $0 | – | -560,311 | -100.0% | -0.27% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.